SCHEMBL2532080

SCHEMBL2532080

CCCCCCCCCCCCC(C)(O)C(=O)OCCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.50
EPHX1 P07099 1/20 0.47
TSHR P16473 3/20 0.46
HCAR2 Q8TDS4 1/20 0.43
RAD52 P43351 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
FAAH O00519 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
ACHE P22303 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2532077 1.00 NAAA (0.50) NAAAEPHX1TSHRHCAR2RAD52
SCHEMBL28265469 1.00 NAAA (0.50) NAAAEPHX1TSHRHCAR2RAD52
SCHEMBL28686443 1.00 NAAA (0.50) NAAAEPHX1TSHRHCAR2RAD52
SCHEMBL17023983 0.94 NAAA (0.47) NAAAEPHX1TSHRHCAR2RAD52
SCHEMBL28299062 0.93 NAAA (0.50) NAAAEPHX1TSHRHCAR2RAD52
SCHEMBL9233388 0.89 ALDH1A1 (0.48) NAAAEPHX1TSHRHCAR2ATM
SCHEMBL4074831 0.87 NAAA (0.52) NAAAEPHX1TSHRHCAR2RAD52
SCHEMBL15011210 0.87 NAAA (0.52) NAAAEPHX1TSHRHCAR2RAD52
SCHEMBL357425 0.87 NAAA (0.52) NAAAEPHX1TSHRHCAR2RAD52
SCHEMBL357426 0.87 MEN1 (0.56) MEN1MAPTKMT2AATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200069979-A1 TOPICAL COMPOSITIONS AND METHODS OF MANUFACTURING THEM IN SPECIFICALLY TREATED STEEL VESSELS OMP, INC. 2020-03-05 US claimed
US-10252088-B2 Topical compositions and methods of manufacturing them in specifically treated steel vessels OBAGI COSMECEUTICALS LLC (US) 2019-04-09 US claimed
US-20140161746-A1 TOPICAL COMPOSITIONS AND METHODS OF MANUFACTURING THEM IN SPECIFICALLY TREATED STEEL VESSELS LSSF II OFFSHORE INVESTMENTS, LP, AS ADMINISTRATIVE AGENT (CA) 2014-06-12 US claimed
US-7534446-B2 Solid cosmetic INTERCOS ITALIA SPA (IT) 2009-05-19 US claimed
US-12343315-B2 Topical cannabinoid compositions for clear skin Avicanna Inc. (CA) 2025-07-01 US disclosed
CN-116847871-A Skin care compositions and methods of use 现代牧场股份有限公司 2023-10-03 CN disclosed
CN-116723820-A Oil-in-water type emulsified cosmetic 花王株式会社 2023-09-08 CN disclosed
CN-116018122-A Cosmetic composition comprising a polymer 欧莱雅 2023-04-25 CN disclosed
CN-115990116-A Oxidative hair dye composition 朋友株式会社 2023-04-21 CN disclosed
CN-115916887-A Amphiphilic alginic acid particles and method for producing same 日清纺控股株式会社 2023-04-04 CN disclosed
US-20230090767-A1 USE OF MICA IN PRESSED POWDER IMERTECH SAS (FR) 2023-03-23 US disclosed
CN-115698186-A Marine biodegradation accelerator 日清纺控股株式会社 2023-02-03 CN disclosed
WO-1998019665-A1 SKIN LIGHTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-14 WO disclosed
EP-0794760-A1 SOLID COSMETIC COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-09-17 EP disclosed
EP-0793481-A1 COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES UNILEVER PLC (GB) 1997-09-10 EP disclosed
EP-0742710-A1 LIPOPHILIC SOLID COSMETIC COMPOSITION COMPRISING ACIDIC DYE THE PROCTER & GAMBLE COMPANY (US) 1996-11-20 EP disclosed
WO-1996017583-A1 SOLID COSMETIC COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1996-06-13 WO disclosed
WO-1995017884-A1 LIPOPHILIC SOLID COSMETIC COMPOSITION COMPRISING ACIDIC DYE THE PROCTER & GAMBLE COMPANY (US) 1995-07-06 WO disclosed
WO-1995005153-A1 COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES UNILEVER PLC (GB) 1995-02-23 WO disclosed
WO-1994027560-A1 SOLID COSMETICS HAVING MOISTURIZING EFFECT THE PROCTER & GAMBLE COMPANY (US) 1994-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10252088-B2 Topical compositions and methods of manufacturing them in specifically treated steel vessels VEGFA, DSG1, POLQ NAAA 3019/4885EPHX1 733/4885TSHR 4828/4885
US-20140161746-A1 TOPICAL COMPOSITIONS AND METHODS OF MANUFACTURING THEM IN SPECIFICALLY TREATED STEEL VESSELS VEGFA, DSG1, POLQ NAAA 3019/4885EPHX1 733/4885TSHR 4828/4885
US-20200069979-A1 TOPICAL COMPOSITIONS AND METHODS OF MANUFACTURING THEM IN SPECIFICALLY TREATED STEEL VESSELS VEGFA, DSG1, POLQ NAAA 3019/4885EPHX1 733/4885TSHR 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.